|
1
|
Ahmad A: Breast cancer: Current
perspectives on the disease status. In: Breast Cancer Metastasis
and Drug Resistance. Springer International Publishing AG, pp51-64,
2019.
|
|
2
|
Caswell-Jin JL, Sun LP, Munoz D, Lu Y, Li
Y, Huang H, Hampton JM, Song J, Jayasekera J, Schechter C, et al:
Analysis of breast cancer mortality in the US-1975 to 2019. JAMA.
331:233–241. 2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Huang X, Song C, Zhang J, Zhu L and Tang
H: Circular RNAs in breast cancer diagnosis, treatment and
prognosis. Oncol Res. 32:241–249. 2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhao X, Zhong Y, Wang X, Shen J and An W:
Advances in circular RNA and its applications. Int J Med Sci.
19:975–985. 2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lei M, Zheng G, Ning Q, Zheng J and Dong
D: Translation and functional roles of circular RNAs in human
cancer. Mol Cancer. 19(30)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Barbagallo D, Caponnetto A, Brex D,
Mirabella F, Barbagallo C, Lauretta G, Morrone A, Certo F, Broggi
G, Caltabiano R, et al: CircSMARCA5 regulates VEGFA mRNA splicing
and angiogenesis in glioblastoma multiforme through the binding of
SRSF1. Cancers (Basel). 11(194)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zheng Q, Bao C, Guo W, Li S, Chen J, Chen
B, Luo Y, Lyu D, Li Y, Shi G, et al: Circular RNA profiling reveals
an abundant circHIPK3 that regulates cell growth by sponging
multiple miRNAs. Nat Commun. 7(11215)2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang C, Yuan W, Yang X, Li P, Wang J, Han
J, Tao J, Li P, Yang H, Lv Q and Zhang W: Circular RNA circ-ITCH
inhibits bladder cancer progression by sponging miR-17/miR-224 and
regulating p21, PTEN expression. Mol Cancer. 17(19)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang M, Bai X, Zeng X, Liu J, Liu F and
Zhang Z: circRNA-miRNA-mRNA in breast cancer. Clin Chim Acta.
523:120–130. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Clough E and Barrett T: The gene
expression omnibus database. In: Methods in molecular biology.
Springer, New York, NY, pp93-110, 2016.
|
|
11
|
Li J, Zhang Y, Gao Y, Cui Y, Liu H, Li M
and Tian Y: Downregulation of HNF1 homeobox B is associated with
drug resistance in ovarian cancer. Oncol Rep. 32:979–988.
2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rasheed Z: Bioinformatics approach: A
powerful tool for microRNA research. Int J Health Sci (Qassim).
11:1–3. 2017.PubMed/NCBI
|
|
13
|
Dhumale SS, Waghela BN and Pathak C:
Quercetin protects necrotic insult and promotes apoptosis by
attenuating the expression of RAGE and its ligand HMGB1 in human
breast adenocarcinoma cells. IUBMB Life. 67:361–373.
2015.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Takakura Y, Hori N, Terada N, Machida M
and Yamaguchi N, Takano H and Yamaguchi N: VGLL3 activates
inflammatory responses by inducing interleukin-1α secretion. FASEB
J. 35(e21996)2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yan J, Ying S and Cai X: MicroRNA-mediated
regulation of HMGB1 in human hepatocellular carcinoma. Biomed Res
Int. 2018(2754941)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tanic M, Yanowski K, Gómez-López G,
Socorro Rodriguez-Pinilla M, Marquez-Rodas I, Osorio A, Pisano DG,
Martinez-Delgado B and Benítez J: MicroRNA expression signatures
for the prediction of BRCA1/2 mutation-associated hereditary breast
cancer in paraffin-embedded formalin-fixed breast tumors. Int J
Cancer. 136:593–602. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
